FDA Inspection 1215344 — RadMD
The FDA completed an inspection of RadMD on August 4, 2023 in Conshohocken, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 4, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Conshohocken, PA (United States)
Additional Details
Sponsor, Contract Research Organization